Superheroes of Development: The Brazilian Hospital with the Highest COVID-19 Survival Rates

Each year, the IDB Group honors development projects that have overcome significant implementation challenges and generate lessons with replicable potential for Latin America and the Caribbean. In 2025, the Superheroes of Development program honored HIAE as one of the winners. This private, nonprofit organization, founded in 1955, was previously supported by IDB Invest during the COVID-19 pandemic.
Superheroes of Development: The Brazilian Hospital with the Highest COVID-19 Survival Rates

Each year, the IDB Group honors development projects that have overcome significant implementation challenges and generate lessons with replicable potential for Latin America and the Caribbean. In 2025, the Superheroes of Development program honored HIAE as one of the winners. This private, nonprofit organization, founded in 1955, was previously supported by IDB Invest during the COVID-19 pandemic.
Superheroes of Development: The Brazilian Hospital with the Highest COVID-19 Survival Rates

Each year, the IDB Group honors development projects that have overcome significant implementation challenges and generate lessons with replicable potential for Latin America and the Caribbean. In 2025, the Superheroes of Development program honored HIAE as one of the winners. This private, nonprofit organization, founded in 1955, was previously supported by IDB Invest during the COVID-19 pandemic.
Microinsurance: The New Frontier for Financial Resilience in Latin America and the Caribbean

Technological innovations that provide insurance to low- and middle-income individuals open up possibilities to enhance the economic stability of families and small and medium-sized enterprises (SMEs) in the face of unexpected events.
Five Drivers Reshaping Finance in Latin America and the Caribbean
Footer
Blog posts written by Bank employees:
Copyright © Inter-American Development Bank ("IDB"). This work is licensed under a Creative Commons IGO 3.0 Attribution-NonCommercial-NoDerivatives. (CC-IGO 3.0 BY-NC-ND) license and may be reproduced with attribution to the IDB and for any non-commercial purpose. No derivative work is allowed. Any dispute related to the use of the works of the IDB that cannot be settled amicably shall be submitted to arbitration pursuant to the UNCITRAL rules. The use of the IDB's name for any purpose other than for attribution, and the use of IDB's logo shall be subject to a separate written license agreement between the IDB and the user and is not authorized as part of this CC- IGO license. Note that link provided above includes additional terms and conditions of the license.
For blogs written by external parties:
For questions concerning copyright for authors that are not IADB employees please complete the contact form for this blog.
The opinions expressed in this blog are those of the authors and do not necessarily reflect the views of the IDB, its Board of Directors, or the countries they represent.
Attribution: in addition to giving attribution to the respective author and copyright owner, as appropriate, we would appreciate if you could include a link that remits back the IDB Blogs website.
To learn more about cookies, click here